Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trial

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Western Pacific
Published
2025-09-27
DOI
https://doi.org/10.1016/j.lanwpc.2025.101700
Primary Topic
Cancer Treatment and Pharmacology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trial

Xinyu Zheng, Fei Xing, Yafei Zhao, Qianshi Xu et al.
The Lancet Regional Health - Western Pacific
Cancer Treatment and Pharmacology
article

Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trial

Xinyu Zheng, Fei Xing, Yafei Zhao, Qianshi Xu, Dong Song, Jinqi Xue, Huilian Shan, Guanglei Chen, Nan Niu, Fang Qiu, Guohui Jiao, Song Yang, Meiyue Tang, Ye Han, Hao Zhang, Mingxin Liu, Guijin He, Hong Xu, Shuo Cao, Yongqing Xu, Ran Zheng, Xi Gu, Caigang Liu
article en

Abstract

No abstract available for this paper.
The Lancet Regional Health - Western PacificVol. 63
Jilin University (CN), First Hospital of Jilin University (CN), Liaoning Cancer Hospital & Institute (CN), China Medical University (CN)
Openalex Percentile: Top 61%
Cancer Treatment and Pharmacology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trial — Xinyu Zheng, Fei Xing, et al. · The Lancet Regional Health - Western Pacific (2025) | TGRS Research Map | TGRS